Stifel Financial Corp Sells 21,615 Shares of Amicus Therapeutics, …

Dec 24, 2024 · Stifel Financial Corp trimmed its holdings in Amicus Therapeutics, Inc. (NASDAQ:FOLD – Free Report) by 19.6% in the 3rd quarter, according to its most recent filing …

CouponFollow Extension

6%
OFF

Stifel Financial Corp Sells 21,615 Shares Of Amicus Therapeutics, …

4 weeks from now

Dec 24, 2024 · Stifel Financial Corp trimmed its holdings in Amicus Therapeutics, Inc. (NASDAQ:FOLD – Free Report) by 19.6% in the 3rd quarter, according to its most recent filing …

defenseworld.net

$965000
OFF

Stifel Financial Corp Has $965,000 Stock Holdings In Aemetis, Inc ...

4 weeks from now

Dec 24, 2024 · Stifel Financial Corp Sells 21,615 Shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD) You might be interested in: Stifel Financial Corp Grows Stake in First Trust …

defenseworld.net

$85959
OFF

Amicus Therapeutics CEO Bradley Campbell Sells $85,959 In Stock

4 weeks from now

Nov 4, 2024 · According to a recent SEC filing, Campbell sold 7,500 shares of Amicus Therapeutics ' common stock, with the sale price averaging $11.4613 per share, totaling …

investing.com

0%
OFF

Stifel Financial Corp Purchases 20,546 Shares Of Corcept …

4 weeks from now

Dec 16, 2024 · Stifel Financial Corp raised its holdings in shares of Corcept Therapeutics Incorporated (NASDAQ:CORT - Free Report) by 30.0% during the third quarter, according to …

marketbeat.com

1%
OFF

Stifel Financial Corp Increases Holdings In Viking Therapeutics, Inc ...

4 weeks from now

Dec 13, 2024 · Stifel Financial Corp grew its holdings in shares of Viking Therapeutics, Inc. (NASDAQ:VKTX - Free Report) by 92.1% in the 3rd quarter, according to the company in its …

marketbeat.com

4%
OFF

State Street Corp Sells 46,217 Shares Of Amicus Therapeutics, Inc ...

4 weeks from now

Dec 16, 2024 · State Street Corp trimmed its stake in Amicus Therapeutics, Inc. (NASDAQ:FOLD – Free Report) by 0.4% during the third quarter, HoldingsChannel.com reports. The fund …

americanbankingnews.com

9%
OFF

Aquestive Therapeutics, Inc. (NASDAQ:AQST) Shares Sold By Stifel ...

4 weeks from now

4 days ago · Stifel Financial Corp cut its stake in Aquestive Therapeutics, Inc. (NASDAQ:AQST - Free Report) by 75.9% during the third quarter, according to its most recent 13F filing with the …

marketbeat.com

4%
OFF

Fulcrum Therapeutics, Inc. (NASDAQ:FULC) Shares Sold By Stifel ...

4 weeks from now

20 hours ago · Stifel Financial Corp lessened its stake in shares of Fulcrum Therapeutics, Inc. (NASDAQ:FULC – Free Report) by 71.4% in the 3rd quarter, according to its most recent 13F …

etfdailynews.com

FAQs about Stifel Financial Corp Sells 21,615 Shares of Amicus Therapeutics, … Coupon?

Does Stifel Financial own Fulcrum Therapeutics?

Stifel Financial Corp lessened its stake in shares of Fulcrum Therapeutics, Inc. (NASDAQ:FULC – Free Report) by 71.4% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 25,025 shares of the company’s stock after selling 62,582 shares during the quarter. ...

Did Stifel Financial buy Halozyme Therapeutics?

Stifel Financial Corp boosted its stake in shares of Halozyme Therapeutics, Inc. (NASDAQ:HALO – Free Report) by 126.3% during the 3rd quarter, HoldingsChannel reports. The institutional investor owned 17,121 shares of the biopharmaceutical company’s stock after purchasing an additional 9,555 shares during the quarter. ...

Who is Stifel Financial Corp?

References to Stifel herein may apply to parent company Stifel Financial Corp. or any of its wholly owned subsidiaries, including Stifel, Nicolaus & Company, Incorporated, Member NYSE, FINRA, and SIPC. Stifel is a full service brokerage and investment banking firm. ...

What can Stifel do for You?

As your trusted advisor, we’ll bring clarity to your financial goals and deliver sound advice to help you navigate uncertain times. From raising capital to structuring mergers and acquisitions, and beyond, Stifel helps companies, organizations, and municipalities navigate complex financial issues. What forces are influencing today's market? ...

What is the Stifel experience?

Learn more about the Stifel Experience for you, and your clients. Stifel is a diversified global wealth management and investment banking company focused on building relationships that help individuals, families, and organizations pursue their financial goals. ...

Did Bank of New York Mellon buy Fulcrum Therapeutics?

Bank of New York Mellon Corp purchased a new stake in shares of Fulcrum Therapeutics during the 2nd quarter worth $1,158,000. Finally, Dimensional Fund Advisors LP boosted its stake in shares of Fulcrum Therapeutics by 13.5% during the 2nd quarter. ...